蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 1825|回复: 1
收起左侧

NICE制定的抵抗抗菌药耐药措施

[复制链接]
药士
发表于 2015-3-9 22:34:13 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
NICE measures for resisting microbial drug resistance
Published on February 18, 2015 at 9:10 AM · No Comments
By Kate Bass BScNICE has published draft guidelines to ensure that antibiotics continue to be effective in treating infections and are not rendered useless through the development of antimicrobial resistance.
The proposed measures are intended to help health and social care commissioners, providers and prescribers promote and monitor the sensible use of antimicrobial medicines in order to prevent infectious micro-organisms from developing resistance to them.
ggw1962 / shutterstock.com
Infections, which are one of the most common causes of disease and complications, are treated using antimicrobial medicines such as antibiotics. Although a new infection is discovered almost every year, very few new antibiotics have been developed. Existing antibiotics are therefore used to treat an ever-growing spectrum of infections and infectious diseases. Consequently, antibiotic prescriptions have been steadily increasing year on year. In 2013–2014, 41.6 million antibacterial prescriptions were issued in England. Despite general practitioners knowing that prescribing rates of antibiotics should be reduced, 97% of patients who ask for antibiotics are prescribed them.
Professor Alastair Hay, Chair of the committee which developed the guidelines, warned:
The more we use antibiotics, the less effective they become as diseases evolve and become resistant to existing antimicrobial medicines...there is a heightened risk in the future that we may not be able to treat infections effectively.
The NICE guideline is the latest of numerous initiatives to tackle growing concerns about increasing antimicrobial resistance by ensuring responsible use of antimicrobial drugs. Although previous guidelines have focussed on specific areas of infection, such as pneumonia, this draft guideline presents evidence-based recommendations across all antimicrobial prescribing. Having assessed the evidence, it proposes the best ways for health and social care practitioners to minimise the risk of antimicrobial resistance.

The latest guideline recognises that patients may put pressure on doctors to prescribe antibiotics, not understanding that this is not necessarily the best course of action. The recommendations thus include taking time to fully discuss with patients the likely nature of their condition and the benefits and harms of immediately prescribing an antimicrobial medicine.
The draft guideline also recommends setting up multidisciplinary antimicrobial stewardship teams that can frequently review antimicrobial prescribing and resistance data across all care settings. The teams would feedback to prescribers, highlighting where prescriptions of antimicrobial drugs outside of local guidelines are not justified.
It is hoped that such actions will preserve the future effectiveness of essential antimicrobobial medicines, such as antibiotics.
Sources: NICE press release https://www.nice.org.uk/news/press-and-media/safeguarding-our-defences-against-disease-nice-sets-out-approaches-to-stop-infections-developing-resistance-to-antimicrobial-medicines
NICE guidelines on antimicrobial prescribinghttp://www.nice.org.uk/guidance/indevelopment/gid-antimicrobialstewardship/documents
Further reading: Nice guidelines on pneumoniahttp://www.nice.org.uk/guidance/cg191



回复

使用道具 举报

药士
发表于 2015-3-9 23:41:40 | 显示全部楼层
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2024-11-28 03:27

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表